Inari Medical, Inc. |
Director |
Common Stock |
541K |
$23M |
$42.41 |
Apr 24, 2024 |
Direct |
Silverback Therapeutics, Inc. |
Director |
Common Stock |
2.07M |
$7.83M |
$3.78 |
Mar 3, 2021 |
Directly owned by USVP X |
eFFECTOR Therapeutics, Inc. |
Director, 10%+ Owner |
Common Stock |
4.38M |
$2.66M |
$0.61 |
Dec 2, 2021 |
Directly owned by USVP X |
Silverback Therapeutics, Inc. |
Director |
Common Stock |
105K |
$397K |
$3.78 |
Mar 3, 2021 |
Directly owned by AFF X |
eFFECTOR Therapeutics, Inc. |
Director, 10%+ Owner |
Common Stock |
140K |
$85.1K |
$0.61 |
Dec 2, 2021 |
Directly owned by AFF X |
Inari Medical, Inc. |
Director |
Common Stock |
335 |
$16.8K |
$50.00 |
Apr 24, 2024 |
Directly Owned by Spouse |
Silverback Therapeutics, Inc. |
Director |
Common Stock |
2.36K |
$8.94K |
$3.78 |
Nov 15, 2021 |
Directly owned by Spouse |
eFFECTOR Therapeutics, Inc. |
Director, 10%+ Owner |
Earn-out Right |
587K |
|
|
Aug 25, 2021 |
By U.S. Venture Partners X, L.P. |
eFFECTOR Therapeutics, Inc. |
Director, 10%+ Owner |
Stock Option (Right to Buy) |
40K |
|
|
Oct 6, 2021 |
Direct |
Edgewise Therapeutics, Inc. |
Director |
Stock Option (Right to Buy) |
20.6K |
|
|
Jun 10, 2024 |
Direct |
eFFECTOR Therapeutics, Inc. |
Director, 10%+ Owner |
Earn-out Right |
18.8K |
|
|
Aug 25, 2021 |
By USVP X Affliliates, L.P. |
Silverback Therapeutics, Inc. |
Director |
Stock Option (right to buy) |
18K |
|
|
Jun 10, 2022 |
Direct |